GlassScriptPhysician profile
Luke Verlinsky
NPI 1346982642
$8,882.54
in general payments reported to CMS, 2019-2025
11 companies · $4,692 in 2025
The $4,692 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $103 · 2023: $228 · 2024: $3,860 · 2025: $4,692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,998 · Food and Beverage: $3,232 · Grant: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,998.12 |
| Food and Beverage | $3,231.62 |
| Grant | $550.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,079.80 | 2023-2025 | T2 Alpha, Mako, Insignia |
| Zimmer Biomet Holdings, INC. | $3,455.65 | 2025 | Affixus, Dvr Anatomic Kickstand |
| Depuy Synthes Sales INC. | $509.38 | 2024-2025 | Na, Tfn-Advance, Va-Lcp |
| Axogen | $239.68 | 2025 | |
| Si-Bone, INC. | $184.83 | 2025 | |
| Mission Medical Distribution, LLC | $127.44 | 2023-2025 | |
| Lima USA, INC. | $125.57 | 2023 | Smr Shoulder |
| Kci USA, INC. | $88.70 | 2022 | |
| Bioventus LLC | $37.44 | 2024 | Durolane |
| Medinc of Texas | $19.95 | 2023 | |
| Convatec INC. | $14.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Verlinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.